Optiscan has been featured in Stockhead's Long Shortz where host Tylah Tully sat down with Optiscan CEO and Managing Director Dr Camile Farah to discuss the US FDA 510(k) submission for InVue, the company’s real-time point-of-care digital surgical microscope.

Dr Farah explains how the technology brings microscopic imaging into the operating room and outlines the pathway towards potential FDA clearance and US commercial rollout.

Watch the full interview here.